Ajanta Pharma’s consolidated Income has grown by 19% to Rs.317.48 crores (Rs.267.31 crores) and consolidated Net Profit increased by 49% to Rs.21.88 crores (Rs.14.66 crores) for the year ended 31st March, 2008

The Board of Directors has recommended a dividend of 25% (Rs.2.50 per Share) for the year under review.Over the last six years, Ajanta Pharma has registered Compounded Annual Growth Rate (CAGR) of 26% in Sales and 45% in Profits.  “We have been consistent in our approach of building brands globally, which is the foundation for our consistent growth”, said Mr. Yogesh Agrawal, Managing Director, Ajanta Pharma.